The use of Lean in Biobanking and Prospective Procurement
I was recently interviewed by Andrea Charles at Pharma IQ about the current trends in biobanking and the future of biorepositories.
For those unfamiliar with my background I've had over 10 years as a supplier in the biobanking industry with an additional 6 years as a customer/user of biomaterials.
If you're interested in lean and the future of the biobanking industry then please give a listen. We talk about:
- Current trends by biotech and pharmaceutical companies
- Why it's critical to use lean in biobanking
- What are the typical bottlenecks of implementation
- What's a minimum clinical data set
- 10 yr - 20 yr vision on biobanking
FoundationBio is a new supplier that listens to its customers
There is a new startup company called FoundationBio whose CEO (Leif Honda) is currently adopting Lean principles to propel his company to becoming the preferred supplier of biomaterials for biotech and phama companies.
His vision is a move towards prospective procurement which allows the VOC (Voice of the Customer) to pull the order thus allowing value to flow and eliminating the wasteful practice of banking excessive inventory.
My favorite quote: "A biobanks only value is given to it by its customers"
